Cydan

Operator of an orphan drug accelerator intended to create therapies that improve the lives of patients living with rare genetic diseases. The company accelerates therapies through clinical, regulatory, and commercial development for treating patients with rare diseases, with approved treatments, enabling patients and families with rare diseases to be treated in a salutary way and helping them recover soon.

New Enterprise Associates

🏥 Healthcare